What the Bill Actually Says — And Why Context Matters
Harvard’s School of Public Health is reporting on a California bill advancing through the legislature that would restrict the sale of certain diet pills and muscle-building supplements to minors. Let’s start with what’s factually true: the bill targets over-the-counter weight-loss and muscle-building products marketed to and purchased by people under 18, citing concerns about disordered eating, unregulated ingredients, and adverse health events in adolescents.
As an attorney who works directly in the supplement and performance-enhancement regulatory space, I’m not going to pretend legislators don’t have legitimate concerns about how these products are marketed to teenagers. Predatory marketing aimed at insecure fifteen-year-olds is a real problem. But the bill — and the Harvard coverage of it — collapses an entire category of substances, dosages, and use cases into a single fear-based narrative. That’s not public health policy. That’s the same broad-brush prohibitionist thinking that has failed us on every substance from alcohol to cannabis to anabolic compounds for the last century.
The Law of Dose Response Is Missing From This Entire Conversation
The first of my 5 Laws of Biochemistry Physics is the Law of Dose Response: everything is dose-dependent. Paracelsus said it 500 years ago — the dose makes the poison. Water itself is lethal at sufficient volume. Yet legislation like this treats “diet pills” and “muscle-building supplements” as a monolithic, uniformly dangerous category, with zero distinction between a caffeine-based thermogenic, a creatine monohydrate product with more published safety data than most FDA-approved drugs (Kreider et al., Journal of the International Society of Sports Nutrition, 2017), and an unregulated stimulant blend with undisclosed ingredients.
This is the core failure of prohibition-style legislation: it can’t legislate nuance. Creatine monohydrate — arguably the most researched ergogenic supplement in existence, with over 1,000 peer-reviewed studies — gets swept into the same bucket as products containing undisclosed DMAA or unregulated ephedra analogs. That’s not protecting youth. That’s regulatory laziness dressed up as public health.
Individual Variation Means Blanket Bans Fail By Design
The second Law — Individual Variation — states that every body responds differently based on genetics, hormonal profile, microbiome, and lifestyle factors. A blanket ban assumes uniform risk across a population that is anything but uniform. Adolescent bodies vary enormously in metabolic rate, endocrine maturity, and baseline health status. Cookie-cutter legislation that doesn’t distinguish between a 17-year-old competitive athlete under medical supervision and an unsupervised 13-year-old buying stimulants online isn’t precision policy — it’s a hammer looking for a nail.
What the Peer-Reviewed Research Actually Shows
Let’s look at the data Harvard’s coverage conveniently leaves out.
- Kanayama & Pope, Molecular and Cellular Endocrinology, 2018 — reviewed long-term health outcomes of performance-enhancing substance use and found that adverse outcomes correlate far more strongly with unsupervised, high-dose, unmonitored use than with the substances themselves. Educated, monitored use produces dramatically different risk profiles than unsupervised abuse.
- Pope et al., JAMA Psychiatry, 2014 — found that psychiatric and physiological risks associated with performance-enhancing compounds are heavily mediated by dosage, duration, and lack of medical oversight — not inherent toxicity of the compound class as a whole.
- Larson et al., Hepatology, 2005 — acetaminophen (Tylenol) overdose remains the leading cause of acute liver failure in the United States, responsible for roughly 500 deaths annually and tens of thousands of ER visits — a legal, unrestricted, over-the-counter drug sitting on every pharmacy shelf in the state that this bill does not touch.
This is the Law of Side Effect Inevitability in action: every intervention carries trade-offs, including the ones we’ve already normalized and placed no age restrictions on. If the standard for restriction is “potential for harm,” Tylenol, energy drinks, and even excessive sugar consumption should be first in line — and they aren’t, because this isn’t really about harm minimization. It’s about which industries have the lobbying power to stay off the target list.
Diminishing Returns: The Argument Prohibitionists Never Make
My third Law — Diminishing Returns — is actually the strongest argument FOR education over bans. More is not better; optimized, informed use consistently outperforms both total abstinence and reckless abuse in outcome studies. Kreider et al. (2017) demonstrated this clearly with creatine protocols: escalating dose past a certain threshold provides no additional benefit and simply increases GI side effects. This is exactly the kind of nuanced, dose-specific education that legislation banning entire categories cannot deliver — but a properly funded, harm-reduction-based education campaign could.
What They Don’t Tell You
Here’s what Harvard’s coverage and the bill’s proponents consistently omit:
1. Banning access doesn’t eliminate demand — it eliminates quality control.
Every prohibition experiment in modern history — alcohol in the 1920s, anabolic steroids under the 1990 Anabolic Steroid Control Act, and now diet pills — produces the same outcome: the demand doesn’t disappear, it moves underground, where there is zero quality control, zero dosage transparency, and zero harm-reduction education. Kanayama & Pope (2018) specifically note that black-market, unsupervised access correlates with worse outcomes than regulated, transparent markets.
2. The bill doesn’t fund education — it funds enforcement.
Nowhere in the coverage is there mention of funding for nutrition education, endocrine health literacy, or body image programs for adolescents — the actual root causes of disordered supplement use. Restriction without education is a policy designed to look active while doing nothing to address underlying behavior.
3. There’s no distinction between regulated dietary ingredients and truly dangerous unregulated stimulants.
Creatine, beta-alanine, and whey protein isolate are lumped rhetorically with unregulated fat-burner blends containing undisclosed synthetic stimulants. This conflation is either scientifically illiterate or deliberately misleading — and it means parents and teens get no actionable information about which products actually warrant concern.
4. Comparative risk is never discussed.
Alcohol kills roughly 140,000 Americans annually (CDC, 2022) and is legally accessible to anyone 21+ with minimal restriction on marketing to young adults. Tylenol overdose is the leading cause of acute liver failure in the U.S. (Larson et al., 2005). Yet neither substance faces legislation remotely as aggressive as what’s being proposed here for supplements with a fraction of the mortality data.
The Law of Biological Momentum and Why “Just Ban It” Never Works
The fifth Law — Biological Momentum — explains why bans consistently underperform education-based harm reduction. The body, and human behavior, resists abrupt change and seeks homeostasis. This is true physiologically (which is why post-cycle therapy exists and why crash dieting fails) and it’s true behaviorally at a population level. Legislating abrupt, total restriction without a transition strategy — education, safer alternatives, medical access pathways — simply pushes behavior into less visible, less safe channels. Sustainable harm reduction beats crash prohibition every time the data has been studied.
Where I Stand — As an Attorney and an Educator
I understand the regulatory landscape here better than most commentators writing about this bill, because navigating FDA, DSHEA, and state-level supplement law is literally part of my legal practice. I’m not arguing that every product marketed to teenagers is safe, appropriately dosed, or ethically sold. Some absolutely are not, and predatory marketing to minors deserves scrutiny.
What I’m arguing is that the solution is education and informed consent — not blanket criminalization of entire ingredient categories based on media panic rather than peer-reviewed toxicology. Real harm reduction means teaching young people (and their parents) how to read a supplement label, understand dose-response relationships, recognize red-flag ingredients, and access qualified medical guidance — not removing their ability to access information and regulated products entirely while leaving far more dangerous, normalized substances untouched.
Body Autonomy Starts With Education, Not Prohibition
This is the same pattern I’ve dismantled article after article on tonyhuge.is: mainstream health media takes a legitimate concern, strips out all dosage context, ignores individual variation, skips the comparative risk data, and delivers a fear-based narrative that supports expanding regulatory control rather than expanding public understanding.
The five Laws of Biochemistry Physics from Better Than Natural exist because the human body doesn’t respond to legislation — it responds to dose, individual biology, protocol design, and time. Real protection for young people comes from arming them with accurate, peer-reviewed information about what they’re putting in their bodies, not from a legislative blanket ban that lumps creatine in with unregulated stimulant blends and calls it a day.
Always consult a qualified healthcare provider before starting any supplement, peptide, or performance-enhancement protocol. Informed consent requires access to complete information — not a filtered, fear-based version of it.
For deeper breakdowns of the peer-reviewed research behind supplements, SARMs, peptides, and TRT — and the regulatory battles shaping your access to them — visit tonyhuge.is. Education is the only real harm reduction. Everything else is just control dressed up as concern.